Myriad Commercially Launches Precise MRD with Select Community Oncologists

Go back to Myriad Commercially Launches Precise MRD with Select Community Oncologists
Myriad Genetics, Inc. (NASDAQ: MYGN) Delayed: 4.05 -0.3 (6.9%)
Previous Close $4.35    52 Week High $45.34 
Open $4.35    52 Week Low $15.92 
Day High $4.35    P/E 1.74 
Day Low $3.99    EPS $2.33 
Volume 798,549